The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| USDA-NRCS On-Farm Conservation Innovation Trials for Federal fiscal year (FY) 2022 |
10.912 |
USDA-NRCS-NHQ-CIGOFT-22-NOFO0001212 |
| Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed) |
93.242, 93.279, 93.313 |
RFA-MH-22-191 |
| Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-22-046 |
| Science and Technology Projects Related to Coal Mining and Reclamation; Applied Science Projects |
15.255 |
S22AS00002 |
| Field Initiated Projects Program (Development) |
93.433 |
HHS-2023-ACL-NIDILRR-IFDV-0000 |
| Service-disabled Veteran Entrepreneurship Training Program (sdvetp) Fy22 |
59.044 |
SB-OVSD-22-001 |
| Small Business Innovation Research (SBIR) program, Phase I |
93.433 |
HHS-2023-ACL-NIDILRR-BISA-0000 |
| Field Initiated Projects Program (Research) |
93.433 |
HHS-2023-ACL-NIDILRR-IFRE-0000 |
| Disability and Rehabilitation Research Projects (DRRP) Program: Burn Model Systems National Data and Statistical Center |
93.433 |
HHS-2023-ACL-NIDILRR-DPBU-0000 |
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) |
93.394 |
RFA-CA-22-040 |
| The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) |
93.394 |
RFA-CA-22-039 |
| Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed) |
93.837, 93.847, 93.865 |
RFA-DK-22-010 |
| Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional) |
93.113, 93.307 |
PAR-22-210 |
| Grants for Injury Control Research Centers (ICRC) |
93.136 |
RFA-CE-24-001 |
| Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) |
93.279, 93.307, 93.310, 93.313, 93.846, 93.866, 93.879 |
RFA-OD-22-015 |
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAS-22-206 |
| Fiscal Year 2022 Solar Manufacturing Incubator Funding Opportunity Announcement |
81.087 |
DE-FOA-0002609 |
| NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-22-216 |
| Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-031 |
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) |
93.213, 93.242, 93.273, 93.279, 93.398 |
PAS-22-207 |
| De-foa-0002582 Pvrd Foa |
81.087 |
DE-FOA-0002582 |
| HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) |
93.213, 93.233, 93.307, 93.313, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 |
RFA-AT-23-002 |
| HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) |
93.213, 93.233, 93.307, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 |
RFA-AT-23-001 |
| HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) |
93.213, 93.242, 93.279, 93.393 |
RFA-DA-23-051 |
| Interventional Cooperative Agreement Program |
96.007 |
ICAP-ICAP-22-001 |
| Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-22-016 |
| OJJDP FY 2022 Youth Violence Prevention Program |
16.548 |
O-OJJDP-2022-171400 |
| Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-22-009 |
| HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required) |
93.213, 93.242, 93.279, 93.393, 93.865, 93.866 |
RFA-DA-23-041 |
| Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) |
93.213, 93.233, 93.279, 93.286, 93.394, 93.397, 93.398, 93.837, 93.838, 93.839, 93.855, 93.989 |
PAR-22-203 |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
93.350 |
RFA-TR-22-029 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-22-189 |
| Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) |
93.847 |
RFA-DK-22-021 |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-22-192 |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-22-193 |
| Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) |
93.242, 93.853 |
RFA-MH-22-280 |
| Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) |
93.242, 93.853 |
RFA-MH-22-281 |
| Miner Safety and Health Training Program - Western United States |
93.262 |
RFA-OH-23-004 |
| Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) |
93.073 |
RFA-DD-23-001 |
| HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional) |
93.213, 93.279, 93.865 |
RFA-DA-23-042 |
Search Results 2881-2920 of 21796
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 [Next] |
